Announcement after extraordinary safety committee meeting
AstraZeneca COVID-19 vaccine, profit outweighs risk
Important facts about the AstraZeneca vaccine have been released.
The European Medicines Agency announced that the profits outweigh the risks of the Corona 19 vaccine from AstraZeneca, a multinational pharmaceutical company.
According to Reuters and the like, the European Medicines Agency said after an extraordinary meeting of the safety committee held on the 18th local time, “it has concluded that the vaccine is not associated with an increased overall risk of blood clots.”
He added that the AstraZeneca vaccine is a safe and effective vaccine.
The World Health Organization (WHO) has also recommended AstraZeneca to continue vaccination, claiming that the benefits of the COVID-19 vaccine outweigh the risks.
On the 18th, the Korea Centers for Disease Control and Prevention Commissioner Jeong Eun-kyung spoke about the symptoms of suspected blood clots after vaccination against Corona 19. “It is the opinion to date that there are no clear signs that it is caused by the vaccine,” he said.
At the general meeting of the National Assembly’s Special Committee on Budget and Accounting, when asked about the side effects of blood clots, Rep. Shin Hyun-young of the Democratic Party together, Chung replied that “blood clots are very common.”
copyright
Wikitree strictly adheres to the news storytelling guidelines.